The efficacy of etoricoxib vs mefenamic acid in the treatment of primary dysmenorrhoea: A randomised comparative trial

Journal of Obstetrics and Gynaecology

Volumn 28, Issue 4, 2008, Pages 424-426

  Azlin, M I Nor ^a   Maryasalwati, I ^a   Norzilawati, M N ^a   Mahdy, Z A ^a   Jamil, M A ^a   Rashid, M R Zainul ^a  

^a UNIVERSITI KEBANGSAAN MALAYSIA   (Malaysia)

Author keywords

Analgesia; Dysmenorrhoea; Etoricoxib; Mefenamic acid; Menorrhagia

Indexed keywords

ETORICOXIB; MEFENAMIC ACID;

ADULT; ANALGESIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIARRHEA; DRUG EFFICACY; DYSMENORRHEA; EPIGASTRIC PAIN; FEMALE; HUMAN; MENORRHAGIA; NAUSEA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CROSS-OVER STUDIES; CYCLOOXYGENASE INHIBITORS; DYSMENORRHEA; FEMALE; HUMANS; MEFENAMIC ACID; PYRIDINES; SULFONES;

EID: 46749110518     PISSN: 01443615     EISSN: 13646893     Source Type: Journal    
DOI: 10.1080/01443610802150051     Document Type: Article

References (19)

1. Banikarim C, Chacko MR, Kelder SH. 2000. Prevalence and impact of dysmenorrhoea on Hispanic female adolescents. Archives of Paediatric and Adolescent Medicine 154:1226-1229.
2. Chan WY, Hill JC. 1978. Determination of menstrual prostaglandin levels in nondysmenorrhoea and dysmenorrhoea subjects. Prostaglandins 15:365.
3. Davis AR, Westhoff CL. 2001. Primary dysmenorrhoea in adolescent girls and treatment with oral contraceptives. Journal of Pediatric and Adolescent Gynecology 14:3-8.
4. Dawood MY, Khan-Dawood FS. 2007a. Clinical efficacy and differential inhibition of menstrual fluid prostaglandin F2 in a randomized, double blind, crossover treatment with placebo, acetaminophen and ibuprofen in primary dysmenorrhoea. American Journal of Obstetrics and Gynecology 196:35.e1-35.e5.
5. Dawood MY, Khan-Dawood FS. 2007b. Differential suppression of menstrual fluid prostaglandin F2a, prostaglandin E2, 6-keto Prostaglandin F1a and thromboxane B2 by suprofen in women with primary dysmenorrhoea. Prostaglandins and Other Lipid Mediators 83:146-153.
6. French L. 2005. Dysmenorrhoea. American Family Physician 71:285-291.
7. Harel Z. 2006. Dysmenorrhoea in adolescent and young adults. Journal of Pediatric and Adolescent Gynecology 19:363-371.
8. Johnson J. 1988. Level of knowledge among adolescent girls regarding effective treatment for dysmenorrhoea. Journal of Adolescent Health 9:398.
9. Klein JR, Litt IF. 1981. Epidemiology of adolescent dysmenorrhoea. Paediatrics 68:661.
10. Lee LK, Chen PC, Lee KK, Kaur J. 2006. Menstruation among adolescent girls in Malaysia: a cross-sectional school survey. Singapore Medical Journal 47:869.
11. Lundstrom V, Green K. 1978. Endogenous levels of prostaglandin F2α and its main metabolites in plasma and endometrium of normal and dysmenorrheic woman. American Journal of Obstetrics and Gynaecology 130:640.
12. Malmstrom K, Kotey P, Cichanowitz N, Daniels S, Desjardins PJ. 2003. Analgesic efficacy of etoricoxib in primary dysmenorrhea: results of a randomized, controlled trial. Gynecologic and Obstetric Investigation 56:65-69.
13. Milsom I, Minic M, Dawood MY, Akin MD, Spann J, Niland NF et al. 2002. Comparison of the efficacy and safety of nonprescription doses of Naproxen and Naproxen Sodium with Ibuprofen, Acetaminophen and placebo in the treatment of primary dysmenorrhoea: A pooled analysis of five studies. Clinical Therapeutics 24:1384-1400.
14. Nirawanti MS, Nazrah ZH, Najwa HM, Nor Shazatul SD, Nor Azlin MI, Zainul Rashid MR. 2006. Dysmenorrhoea in our community: Grimace to dignity? International Medical Journal 5:2.Available at: http://www.e-imj.com/Vol5-No2/ Vol5-No2-B2.htm.
15. Simopoulos A. 1991. Omega-3 fatty acids in health and disease and in growth and development. American Journal of Clinical Nutrition 54:438.
16. Raine-Fenning. 2005. Dysmenorrhoea. Current Obstetrics and Gynaecology 15:394-401.
17. Rees MC, DiMarzo V, Tippins JR, Morris HR, Turnbull AC. 1987. Leukotriene release by endometrium and myometrium throughout the menstrual cycle in dysmenorrhoea and menorrhagia. Journal of Endocrinology 113:291.
18. Roy S. 1983. A double-blind comparison of a propionic acid derivatives (Ibuprofen) and a fenamate (mefenamic acid) in the treatment of dysmenorrhoea. Obstetrics and Gynecology 62:628.
19. Twigg J. 2002. Dysmenorrhoea. Current Obstetrics and Gynaecology 12:341-345.